Multi-cancer early detection is on the horizon

Before cancers become deadly, signs of their presence can show up in escaped strands of DNA and other tell-tale molecules. Technical leaps are making it possible to find these signals in blood,...

Highlights from the Fifth Early Detection of Cancer Conference

Advancing the early detection of lethal cancers is fundamental to treating patients more effectively. One of the most important factors in cancer survival is diagnosis at an early stage. Screening...

Early detection: a powerful way to improve cancer survival

Advancing the early detection of lethal cancers is fundamental to treating patients more effectively. But the path forward is not easy to see. It will require multi-disciplinary collaborations,...

Cancer genome study reveals big window for early detection

Tell-tale DNA errors arise years before tumors become dangerous. For cancers that can’t currently be detected early, a new discovery suggests there may be a large window of time in which to look...

Bringing together the leaders in cancer early detection

The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...

Oregon’s colonoscopy trailblazer steps into new leadership role

Colorectal screening, primarily by colonoscopy, contributed to a steep drop in cancer incidence (Yang et al. 2014). David Lieberman, M.D., professor and head of gastroenterology and hepatology in...

Making sense of colorectal cancer screening choices

Colorectal cancer is the third most common cause of cancer death among men and women in the U.S. But there is shockingly large regional variation in mortality, in part because of sharp differences...

Clearing the quandary of cancer early detection

For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading. But efforts to detect cancers early have led to a...

New funding for a dire need: Pancreas cancer early detection

With a $250,000 award from the Pancreatic Cancer Action Network, researchers will seek to validate biomarkers able to detect pancreas cancer months or years before patients experience overt symptoms...